As FOSL1 is a key glioma regulator, it is expected that other TRPM7-mediated FOSL1 activations could contribute to glioma pathogenesis, other than HOTAIR and miR-301a-3p. This evidence concerns the gene TRPM7 and central nervous system cancer.